Saturday, January 29, 2022

Up to RM1 million compound for companies flouting SOPs after amendments to Act 342

Health Minister Khairy Jamaluddin says the maximum amount will remain at RM10,000 for individuals.

Other News

Companies, factories and government agencies violating the SOPs set to control the spread of Covid-19 can be compounded up to RM1 million following amendments to the Prevention and Control of Infectious Diseases Act 1998 (Act 342), says Health Minister Khairy Jamaluddin.

He said the increase in compound amount is among the amendments to be tabled in the Dewan Rakyat on Thursday.

Khairy said the compound would be higher for repeated offences, based on assessments.

Currently, the maximum amount that can be imposed on errant companies and factories is RM50,000, he said.

“For individuals, the maximum amount of compound will remain at RM10,000 but based on the current situation involving home quarantine implementation and so on, amendments will also involve matters such as the installation of surveillance devices,” he said when appearing on a programme with RTM last night.

Khairy said the amendments were also crucial in terms of enforcement as they would involve the delegation of power to allow enforcement to be carried out not only by officers from the health ministry but also by local authorities.

He said it would involve clear guidelines so that there would be no issue of abuse of power, stressing that the move is for “future proofing” to affect behavioural changes among the communities.

It is also to refine the implementation of infectious diseases control to be more effective and efficient, he added.

Khairy stressed that the ministry is always committed and takes a firm stand to ensure the people’s safety by implementing efforts to control the Covid-19 pandemic, adding that the public should continue to comply with the prescribed SOPs.

Follow us on Telegram for the latest updates: https://t.me/malaysianow

Subscribe to our newsletter

To be updated with all the latest news and analyses.

Related Articles